Recursion to Participate in Upcoming Investor Conferences

(marketscreener.com) SALT LAKE CITY, Nov. 2, 2022 /PRNewswire/ -- Recursion , the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following investor conferences: Credit...https://www.marketscreener.com/quote/stock/RECURSION-PHARMACEUTICALS-121456074/news/Recursion-to-Participate-in-Upcoming-Investor-Conferences-42177150/?utm_medium=RSS&utm_content=20221102